SVB Leerink Biopharma Private Company Connect

Glycostem is honored being seleced to be part of SVB Leerink Biopharma Private Company Connect on 7th to 9th July. It is a series of 1:1 between investors and Glycostem, one of the last formally organized investor conferences before the European summer break.

Virtual European Biotech Investor Day

Glycostem CEO Troels Jordansen presents on 25th June at the upcoming Virtual European Biotech Investor Day 2020 hosted by Solebury Trout, Goodwin, Deutsche Bank and Nasdaq. 

Jefferies Virtual Healthcare Conference

Glycostem is  invited to the second largest investor conference: the Jefferies Virtual Healthcare Conference on 4th July. The interest in off-the-shelf NK-cells with no CRS issues is increasing rapidly.

ACCESS CHINA Online Partnering Day

Glycostem presents at ACCESS CHINA Online Partnering Day on 15th May, 2020. ACCESS CHINA Partnering Day is the largest online corporate access event between China and Western Biopharma Industry. Glycostem is looking for investors and partnering opportunities.

Glycostem Presents at ASGCT 2020

On 14th May Glycostem presents virtually a poster at ASGCT 2020 about oNKord® “off-the-shelf” NK therapy closed system manufacturing process and clinical potential in AML, with a perspective on CAR-NK and other NK innovative therapies.


Glycostem participates in Bio CEO on 10th and 11th February 2020 in New York. Glycostem’s CEO Troels Jordansen provides an update on Glycostem.